Departed
Mark Pomeranz
Director
Motus GI Holdings, Inc.
Timothy Moran, Scott Durbin, Sonja Nelson, Mark Pomeranz and Gary Pruden resigned from the Board of Directors
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7801–7850 of 75441
Departed
Kaveh Varjavand
Director
BCAL ·
California BanCorp \ CA
Irwin Golds, Kaveh Varjavand and Anita Wolman (the “Retiring Directors”) retired from the SCB Board effective at the Effective Time.
Departed
Irwin Golds
Director
BCAL ·
California BanCorp \ CA
Irwin Golds, Kaveh Varjavand and Anita Wolman (the “Retiring Directors”) retired from the SCB Board effective at the Effective Time.
Departed
Anita Wolman
Director
BCAL ·
California BanCorp \ CA
Irwin Golds, Kaveh Varjavand and Anita Wolman (the “Retiring Directors”) retired from the SCB Board effective at the Effective Time.
Departed
Grace F. L. Peng
Director
Cetus Capital Acquisition Corp.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Departed
Chung-Yi Sun
Director
Cetus Capital Acquisition Corp.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Departed
Jung-Te Chang
Director
Cetus Capital Acquisition Corp.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Departed
Lin Bao
Director
Cetus Capital Acquisition Corp.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Departed
Chung-Yi Sun
Executive Officer
Cetus Capital Acquisition Corp.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Departed
Cheng-Nan Wu
Executive Officer
Cetus Capital Acquisition Corp.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Departed
Cheng-Nan Wu
Director
Cetus Capital Acquisition Corp.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Departed
Shimon Rapp
Director
GCTK ·
Glucotrack, Inc.
On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.
Departed
Andrew Sycoff
Director
GCTK ·
Glucotrack, Inc.
On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.
Departed
Bradley Weston
Director
VRA ·
Vera Bradley, Inc.
On July 26, 2024, Bradley (“Brad”) Weston provided notice of his decision to resign from the Board of Directors (the “Board”) of Vera Bradley, Inc. (the “Company”) effective August 30, 2024.
Departed
Joel V. Staff
Director
KMI ·
KINDER MORGAN, INC.
On July 30, 2024, Joel V. Staff notified Kinder Morgan, Inc. (“KMI”) that he will retire from KMI’s Board of Directors effective August 1, 2024.
Departed
Solomon Adote
Director
VISM ·
VISIUM TECHNOLOGIES, INC.
On July 25, 2024, the Company received written notice from Solomon Adote of his resignation as a member of the Board of Directors
Departed
Emmanuel Esaka
Director
VISM ·
VISIUM TECHNOLOGIES, INC.
On July 25, 2024, the Company received written notice from Dr. Emmanuel Esaka of his resignation as a member of the Board of Directors
Departed
David J. Anderson
executive vice president and chief financial officer
CTVA ·
Corteva, Inc.
David J. Anderson, executive vice president and chief financial officer, notified the Company on July 26, 2024, of his intent to retire effective September 16, 2024.
Departed
Peter M. Fasolo
Director
KVUE ·
Kenvue Inc.
Peter M. Fasolo, Ph.D., and Joseph J. Wolk each informed Kenvue Inc. (the "Company") and its Board of Directors (the "Board") of their decision to resign from the Board, effective as of December 1, 2024.
Departed
Joseph J. Wolk
Director
KVUE ·
Kenvue Inc.
Peter M. Fasolo, Ph.D., and Joseph J. Wolk each informed Kenvue Inc. (the "Company") and its Board of Directors (the "Board") of their decision to resign from the Board, effective as of December 1, 2024.
Departed
Patrick Roney
Executive Chairman of the Board
Vintage Wine Estates, Inc.
On July 29, 2024, Patrick Roney notified the Board of his decision to resign from his position as Executive Chairman of the Board, effective August 1, 2024.
Departed
Carrie Lazorchak
Chief Revenue Officer
DH ·
Definitive Healthcare Corp.
On July 24, 2024, Carrie Lazorchak, the Chief Revenue Officer of the Company, provided the Company with notice of her resignation, effective August 2, 2024.
Departed
Carol C. Lam
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
Scott B. Brown
Chief Financial Officer and Secretary
Tracon Pharmaceuticals, Inc.
In connection with the Reduction in Force, Scott B. Brown, CPA, Chief Financial Officer and Secretary will cease serving as an officer of the Company effective July 31, 2024.
Departed
Lisa Johnson-Pratt
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
Saundra Pelletier
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
Charles P. Theuer
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
J. Rainer Twiford
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
Stephen T. Worland
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
Martin A. Mattingly
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
Charles P. Theuer
President and Chief Executive Officer
Tracon Pharmaceuticals, Inc.
On July 30, 2024, Charles P. Theuer, M.D., Ph.D., tendered his resignation as the Company’s President and Chief Executive Officer, to be effective as of July 31, 2024.
Departed
William R. LaRue
Director
Tracon Pharmaceuticals, Inc.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
Departed
Michael J. Burbach
Chief Operating Officer
RYZ ·
Ryerson Holding Corp
On July 30, 2024, Michael J. Burbach, age 63, notified the Company of his intent to retire from his position as our Chief Operating Officer, effective December 31, 2024.
Departed
Kathy Liu
Head of Technology Strategy
Project Energy Reimagined Acquisition Corp.
the following officers of PERAC resigned from their respective positions: David Roberts (Chief Operating Officer), Tim Dummer (Head of Business Strategy) and Kathy Liu (Head of Technology Strategy)
Departed
Nina Jensen
Director
Project Energy Reimagined Acquisition Corp.
each of Michael Browning (Chairman of the Board), Eric Spiegel and Nina Jensen ceased to be a director of PERAC
Departed
Michael Browning
Chairman of the Board
Project Energy Reimagined Acquisition Corp.
each of Michael Browning (Chairman of the Board), Eric Spiegel and Nina Jensen ceased to be a director of PERAC
Departed
Eric Spiegel
Director
Project Energy Reimagined Acquisition Corp.
each of Michael Browning (Chairman of the Board), Eric Spiegel and Nina Jensen ceased to be a director of PERAC
Departed
David Roberts
Chief Operating Officer
Project Energy Reimagined Acquisition Corp.
the following officers of PERAC resigned from their respective positions: David Roberts (Chief Operating Officer), Tim Dummer (Head of Business Strategy) and Kathy Liu (Head of Technology Strategy)
Departed
Tim Dummer
Head of Business Strategy
Project Energy Reimagined Acquisition Corp.
the following officers of PERAC resigned from their respective positions: David Roberts (Chief Operating Officer), Tim Dummer (Head of Business Strategy) and Kathy Liu (Head of Technology Strategy)
Departed
Frank Pelzer
Executive Vice President and Chief Financial Officer
FFIV ·
F5, INC.
On July 26, 2024, Frank Pelzer, Executive Vice President and Chief Financial Officer of F5, Inc. (the “Company”), informed the Company of his plans to retire during the Company’s first fiscal quarter 2025, which ends December 31, 2024.
Departed
Stephen Goodman
Director
LCGMF ·
LION COPPER & GOLD CORP.
Stephen Goodman ceased to act as a director of the Company on July 26, 2024.
Departed
(interim)
Donald B. Murray
Chairman and Director
RGP ·
RESOURCES CONNECTION, INC.
On July 26, 2024, Donald B. Murray notified Resources Connection, Inc. (the “Company”) of his resignation from his position as the Chairman and a member of the Board of Directors (the “Board”) of the Company.
Departed
Christopher S. Sotos
President and Chief Executive Officer
Clearway Energy LLC
Christopher S. Sotos informed Clearway Energy, Inc. (“ Clearway, Inc. ”), the parent company of the Company, on April 30, 2024 that, effective as of June 30, 2024, he will move on from his position as President and Chief Executive Officer of Clearway, Inc. and the Company.
Departed
Nat Krishnamurti
Vice President, Chief Financial Officer and Secretary
HDSN ·
HUDSON TECHNOLOGIES INC /NY
Simultaneously, on such date, Nat Krishnamurti stepped down, effective immediately, from his positions as Vice President, Chief Financial Officer and Secretary of the Company.
Departed
Todd Penegor
director
PRGO ·
PERRIGO Co plc
On July 24, 2024, Todd Penegor advised Perrigo Company plc (“Perrigo” or the “Company”) that he would be resigning from the Company’s board of directors (the “Board”), effective July 31, 2024.
Departed
Randall Theisen
Head of Corporate Affairs
WAL ·
WESTERN ALLIANCE BANCORPORATION
the retirement of Randall Theisen from the head of the Company’s Corporate Affairs.
Departed
J. Kelly Ardrey, Jr.
Chief Accounting Officer
WAL ·
WESTERN ALLIANCE BANCORPORATION
J. Kelly Ardrey, Jr., the Company’s Chief Accounting Officer, notified the Company of his intention to retire from the Company, effective March 3, 2025.
Departed
Jennifer Fox
Executive Vice President External Affairs, General Counsel and Corporate Secretary
EBS ·
Emergent BioSolutions Inc.
Emergent BioSolutions, Inc. (the “Company”) announced that Jennifer Fox is resigning as Executive Vice President External Affairs, General Counsel and Corporate Secretary of the Company to pursue an opportunity outside of the Company and will continue in her current role until August 16, 2024.
Departed
Joe Aric Peters
member of the Board of Directors
BUKS ·
BUTLER NATIONAL CORP
On July 26, 2024, Joe Aric Peters notified Butler National Corporation (the “Company”) that he resigned as a member of the Company’s Board of Directors (the “Board”) effective immediately.
Departed
Peter Gross
Director
POLA ·
Polar Power, Inc.
As previously disclosed, Peter Gross, a member of the Board of Directors (the “Board”) of Polar Power, Inc. (the “Company”), resigned as a member of the Board of Directors of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.